InvestorStemCell.com is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements in the regenerative medicine sector.

World Stem Cell Report To Be Published In Regenerative Medicine

Regenerative Medicine joins 2011 World Stem Cell Summit in Pasadena as Platinum Media Sponsor.

curasan AG expects to make a considerable profit instead of the two million euro loss announced for the financial year 2010

Key Patent Covers Fundamental Methods for Producing RPE Cells from Embryonic Stem Cells Including IP Used in Phase I Trial to Treat Patients with Stargardt's Macular Dystrophy.

curasan AG has concluded a contract with Matricel GmbH, Herzogenrath, which secures exclusive rights for both companies over a jointly developed new product line

curasan AG, listed in the General Standard of the German Stock Exchange, was able to achieve an annual surplus of 0.2 million Euro in the fiscal year 2009

The employees of curasan AG awaited the recently produced batch of Cerasorb® M with particular excitement

In Germany alone, every year about 800,000 tooth implants are placed. In the case of almost every second patient bone augmentation is necessary, because the jawbone atrophy is already too advanced.

curasan AG, listed in the General Standard of the Deutsche Börse AG, is commencing the sale, through a subsidiary, of its synthetic bone regeneration material Cerasorb® M Ortho in the United States